Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 2
1947 4
1948 9
1949 4
1950 13
1951 12
1952 13
1953 8
1954 14
1955 9
1956 8
1957 7
1958 8
1959 12
1960 8
1961 11
1962 17
1963 18
1964 18
1965 8
1966 2
1967 17
1968 22
1969 24
1970 39
1971 25
1972 40
1973 36
1974 41
1975 8
1976 13
1977 15
1978 7
1979 19
1980 15
1981 15
1982 14
1983 7
1984 10
1985 12
1986 16
1987 17
1988 9
1989 12
1990 19
1991 22
1992 25
1993 18
1994 20
1995 93
1996 178
1997 223
1998 263
1999 325
2000 305
2001 391
2002 333
2003 372
2004 449
2005 405
2006 410
2007 457
2008 375
2009 439
2010 441
2011 405
2012 461
2013 495
2014 520
2015 578
2016 600
2017 645
2018 624
2019 288
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

10,078 results
Results by year
Filters applied: . Clear all
Page 1
Management of Radiation Proctitis
Tabaja L and Sidani SM. Dig Dis Sci 2018 - Review. PMID 29948565
Medical options such as anti-inflammatory agents, antioxidants, formalin application, and hyperbaric oxygen may improve bleeding related to chronic radiation proctitis. ...
Medical options such as anti-inflammatory agents, antioxidants, formalin application, and hyperbaric oxygen may improve bleeding rela …
ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.
Marks SL, et al. J Vet Intern Med 2018. PMID 30378711 Free PMC article.
The gastrointestinal (GI) mucosal barrier is continuously exposed to noxious toxins, reactive oxygen species, microbes, and drugs, leading to the development of inflammatory, erosive, and ultimately ulcerative lesions. ...
The gastrointestinal (GI) mucosal barrier is continuously exposed to noxious toxins, reactive oxygen species, microbes, and drugs, le …
Emerging Therapies for Inflammatory Bowel Disease
Weisshof R, et al. Adv Ther 2018 - Review. PMID 30374806 Free PMC article.
Other agents are currently being developed at various stages of clinical trials including anti-adhesion agents such as etrolizumab and abrilumab, JAK inhibitors such as tofacitinib, and anti-trafficking molecules. ...
Other agents are currently being developed at various stages of clinical trials including anti-adhesion agents such as etroliz …
New developments in the treatment of gastroparesis and functional dyspepsia
Tack J and Camilleri M. Curr Opin Pharmacol 2018 - Review. PMID 30245474
Functional dyspepsia (FD) and gastroparesis are frequent causes of upper gastrointestinal symptoms such as postprandial fullness, early satiation, epigastric pain or burning, upper abdominal bloating, bothersome belching, nausea and vomiting. ...For gastroparesis, recently studied agents include the prokinetic ghrelin agonist relamorelin, the prokinetic serotonergic agents velusetrag and prucalopride, the anti-emetic aprepitant and per-endoscopic pyloric myotomy procedures....
Functional dyspepsia (FD) and gastroparesis are frequent causes of upper gastrointestinal symptoms such as postprandial fullness, ear …
Novel oral-targeted therapies for mucosal healing in ulcerative colitis
Antonelli E, et al. World J Gastroenterol 2018 - Review. PMID 30598577 Free PMC article.
Consequently, interest is focusing on the development of new substances for UC therapy, and new oral agents are in the pipeline. ...
Consequently, interest is focusing on the development of new substances for UC therapy, and new oral agents are in the pipeline. ...
Managing Risks with Biologics
Click B and Regueiro M. Curr Gastroenterol Rep 2019 - Review. PMID 30635807
We review the clinical trial and real-world safety data to date on these agents as well as review new data and considerations with anti-tumor necrosis factor agents. ...Understanding the risks of new agents in inflammatory bowel disease, potential mitigating strategies, and management considerations is important to achieving and maintaining clinical outcomes in IBD patients....
We review the clinical trial and real-world safety data to date on these agents as well as review new data and considerations with an …
10,078 results
Jump to page
Feedback